Raymond James, Sym
This was the stock's second consecutive day of gains.
Larry Adam, Raymond James chief investment officer, joins 'The Exchange' to discuss key takeaways from Big Tech earnings, ...
Raymond James is seeing a beneficial shift to advisory as well as recovering M&A activity, which may continue. Read why I ...
Raymond James resumed coverage of Regenxbio (RGNX) with an Outperform rating and $27 price target The firm expects the launch of Elevidys and ...
Raymond James downgraded Symbotic Inc (NASDAQ:SYM) to "Market Perform" from "Outperform" on disappointing first-quarter ...
LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...
Stock analysts at Seaport Res Ptn raised their Q3 2025 earnings per share estimates for Raymond James in a report released on ...
Booz Allen Hamilton Holding ( NYSE: BAH) on Monday was upgraded to Outperform from a previous investment rating of Market ...
Following similar moves by other large firms, Raymond James says quarterly advisor counts aren’t the most meaningful measure ...
Jeffrey Dobyns, the president of SageSpring Wealth Partners, says he and his colleagues were looking for greater freedom to ...
Raymond James lowered the firm’s price target on Corpay (CPAY) to $417 from $434 and keeps an Outperform rating on the shares. Corpay reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback